Viruses 2011, 3(6), 677-713; doi:10.3390/v3060677

Gammaretroviral Vectors: Biology, Technology and Application

Department of Experimental Hematology, Hannover Medical School, OE6960-HBZ, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany
* Authors to whom correspondence should be addressed.
Received: 8 March 2011; in revised form: 3 May 2011 / Accepted: 9 May 2011 / Published: 3 June 2011
(This article belongs to the Special Issue Retroviral Vectors)
PDF Full-text Download PDF Full-Text [835 KB, uploaded 3 June 2011 15:08 CEST]
Abstract: Retroviruses are evolutionary optimized gene carriers that have naturally adapted to their hosts to efficiently deliver their nucleic acids into the target cell chromatin, thereby overcoming natural cellular barriers. Here we will review—starting with a deeper look into retroviral biology—how Murine Leukemia Virus (MLV), a simple gammaretrovirus, can be converted into an efficient vehicle of genetic therapeutics. Furthermore, we will describe how more rational vector backbones can be designed and how these so-called self-inactivating vectors can be pseudotyped and produced. Finally, we will provide an overview on existing clinical trials and how biosafety can be improved.
Keywords: Murine Leukemia Virus; gammaretroviral; split packaging design; SIN vector

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Maetzig, T.; Galla, M.; Baum, C.; Schambach, A. Gammaretroviral Vectors: Biology, Technology and Application. Viruses 2011, 3, 677-713.

AMA Style

Maetzig T, Galla M, Baum C, Schambach A. Gammaretroviral Vectors: Biology, Technology and Application. Viruses. 2011; 3(6):677-713.

Chicago/Turabian Style

Maetzig, Tobias; Galla, Melanie; Baum, Christopher; Schambach, Axel. 2011. "Gammaretroviral Vectors: Biology, Technology and Application." Viruses 3, no. 6: 677-713.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert